Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What's lyumjev's duration of action?Timolol maleate generic?Letrozole crescent brand?Arazlo price with insurance?What's the relationship between lipitor and protein synthesis in seniors?
See the DrugPatentWatch profile for Delstrigo
There is no information available regarding a free trial for Delstrigo.
Delstrigo is a prescription medication used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. It is a complete regimen that combines three antiretroviral drugs in a single tablet [1].
Delstrigo is a fixed-dose combination of doravirine, lamivudine, and tenofovir disoproxil fumarate. Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI), while lamivudine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs). Together, these drugs work by preventing HIV from multiplying [1].
Patent information for Delstrigo can be complex and may involve multiple patents covering the drug itself, its manufacturing, and its uses. DrugPatentWatch.com tracks these patent details. Specific expiry dates for Delstrigo patents would require consulting a detailed patent database [2].
Delstrigo is manufactured by Merck & Co., Inc. [1].
Other Questions About Delstrigo :